TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Operating Margin (2020 - 2026)

Updated

TScan Therapeutics' Operating Margin came in at -5636.69% for Q3 2026, down 4161.10 percentage points from -1475.59% a year earlier and down 2735.36 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, TScan Therapeutics reported Operating Margin of -2246.84%, down 481.83 percentage points year-over-year; for FY2025, it came in at -1315.38%, up 3472.30 percentage points from FY2024.

  • Operating Margin carries a five-year change of +1102.41 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -4787.68% in FY2024 (-4343.68 pp), -444.00% in FY2023 (+48.32 pp), -492.32% in FY2022 (-12.68 pp) and -479.65% in FY2021 (+1938.14 pp).
  • The Q3 2026 figure represents the lowest quarterly Operating Margin since Q2 2024.
  • Year-over-year, Operating Margin has declined for three consecutive quarters, with an average year-over-year change of +359.84 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q2 2025 (a gain of 5107.95 percentage points), and the weakest in Q2 2024 (a drop of 5582.79 percentage points).
  • Business Quant data shows TCRX's Operating Margin at -2901.33% (Q2 2026), -2967.31% (Q1 2026) and -929.41% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -5,636.69%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -5,636.69%
Jun 30, 2026 -2,901.33%
Mar 31, 2026 -2,967.31%
Dec 31, 2025 -929.41%
Sep 30, 2025 -1,475.59%
Jun 30, 2025 -1,256.60%
Mar 31, 2025 -1,669.74%
Dec 31, 2024 -5,520.60%
Sep 30, 2024 -3,109.82%
Jun 30, 2024 -6,364.55%
Mar 31, 2024 -5,542.93%
Dec 31, 2023 -296.17%
Sep 30, 2023 -636.69%
Jun 30, 2023 -781.77%
Mar 31, 2023 -334.31%
Dec 31, 2022 -602.55%
Sep 30, 2022 -492.95%
Jun 30, 2022 -375.89%
Mar 31, 2022 -535.02%
Dec 31, 2021 -497.62%
API Access

TScan Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY